Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetuximab and Stereotactic Radiotherapy in Recurrent Head and Neck Cancer
NCT00738868Phase 2Completed
- Sponsor
- Centre Oscar Lambret
- Start
- Oct 2007
- Primary completion
- May 2011
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of KL-140 in head and neck squamous cell carcinoma (HNSCC), sponsored by Centre Oscar Lambret. Started Oct 2007; status: completed.
02
Drugs
KL-140
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT00738868.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00738868.